Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director/PDMR Shareholding

17th Apr 2014 16:50

RNS Number : 1273F
GlaxoSmithKline PLC
17 April 2014
 



 Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

 

 

The Administrators of the GlaxoSmithKline 2009 Performance Share Plan (the Plan) notified the Company and the under-mentioned Directors and Persons Discharging Managerial Responsibility (PDMR) on 16 April 2014 of the following increases in their notional interests in Ordinary Shares at a price of 1581.50 pence per Ordinary Share and American Depositary Shares (ADSs) at a price of $52.55 per ADS following the notional re-investment of the dividend paid to shareholders on 10 April 2014.

 

 

Director/PDMR

Ordinary Shares

ADSs

Sir Andrew Witty

19,564.837

Dr M M Slaoui

5,637.905

Mr S Dingemans

8,217.586

Mr S M Bicknell

1,325.959

Mr R G Connor

2,687.452

Mrs D P Connelly

2,344.551

Mr J Ford

303.243

Mr S A Hussain

6,666.166

Mr W C Louv

1,653.860

Mr D S Redfern

2,829.821

Ms C Thomas

3,905.590

Mr P C Thomson

1,905.093

Mr D E Troy

3,350.705

Dr P J T Vallance

8,136.668

Ms E Walmsley

4,729.965

Mrs V A Whyte

541.530

 

 

 

The notional dividends accrued will be paid out in proportion to the percentage of participants' Plan holdings that vest following the end of the relevant measurement period.

 

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

 

 

V A Whyte

Company Secretary

17 April 2014

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEDLFFZZFZBBK

Related Shares:

Glaxosmithkline
FTSE 100 Latest
Value8,632.33
Change89.77